Antiviral activity and safety of 873140, a novel CCR5 antagonist, during short-term monotherapy in HIV-infected adultsJacob Lalezari, Stephen C. Piscitelli, Melanie Thompson et al.|AIDS|2005Cited by 111
Prevalence of Pretreatment and Acquired HIV-1 Mutations Associated with Resistance to Lamivudine or Rilpivirine: A Systematic ReviewVani Vannappagari, Michael Aboud, Dannae Brown et al.|Antiviral Therapy|2018Cited by 18